Mini lung machine tested on tiniest patients

NCT ID NCT06750536

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a small device called the MiniLung petite kit, which helps oxygenate blood and remove carbon dioxide in newborns and children weighing 2 to 8 kilograms who have severe breathing or heart failure. The device works with a console to temporarily take over the work of the lungs and heart. Researchers want to see if it safely improves oxygen levels and stabilizes vital signs within 24 hours. The study will enroll 20 participants and observe their progress.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MiniLung petite kit (a miniaturized ECMO device used with the Xenios console)
What this could lead to
If successful, this could provide a safe and effective way to support breathing and heart function in very small infants with life-threatening respiratory or cardiac failure.
What could go wrong
This is a small, early observational study with only 20 participants, so results may not apply to all patients. ECMO itself carries risks like bleeding, infection, and blood clots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LUNG INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universitätsklinikum Mannheim

    RECRUITING

    Mannheim, 68167, Germany

  • Universitätsklinkum Bonn

    RECRUITING

    Bonn, North Rhine-Westphalia, 53127, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.